Pacific Biosciences of California, Inc. (PACB) Stock Analysis — Probabli.AI
AI-powered analysis for PACB (Pacific Biosciences of California, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $1.39 · Market cap: $401.7M · AI consensus: Bullish
Pacific Biosciences of California, Inc. showcases high potential due to exceptionally strong revenue growth projection, positive earnings streaks, and strategic partnerships. While regulatory and leadership challenges may pose short-term threats, the company’s innovative edge and expanding market presence position it for significant upside over the next decade.
Probabilistic 1-Year Outlook
- Bull 6000% · Neutral 3000% · Bear 1000%
- Due to the strong growth estimate and recent positive catalysts, PACB can outperform the market in the short term. However, some risks and headwinds may limit upside potential.
5-Year Outlook
- Bull 6500% · Neutral 2500% · Bear 1000%
SWOT Highlights
- Strength: Exceptional revenue growth forecast.
- Strength: Strong earnings beat streak.
- Risk: Recent regulatory scrutiny.
- Risk: Potential impact of leadership changes.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
5 Wall Street analysts rate PACB a BUY with a mean price target of $2.1.
Analysis generated Mar 25, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/PACB.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.